Kyle D. Kuvalanka

Chief Business Officer, Blueprint Medicines Corp.

Companies

Aktis Oncology, Inc.Chief financial officer Jan 8, 2026 to now¹
Syros Pharmaceuticals, Inc.Chief operating officer Jun 29, 2016 to Feb 13, 2017²
Blueprint Medicines CorpChief Business Officer Apr 30, 2015 to Apr 30, 2015³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAktis Oncology, Inc., Chief financial officer
2
SEC EDGARSyros Pharmaceuticals, Inc., Chief operating officer
3
SEC EDGARBlueprint Medicines Corp, Chief Business Officer